China Reinsurance (Group) (HKSE:01508) Research & Development: HK$0 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:01508 China Reinsurance (Group) Corp HKSE:01508
78 GF Score
Price HK$1.24
GF Value HK$1.14
Valuation Fairly Valued
! 2 Warning Signs
View Full Analysis

What is China Reinsurance (Group) Research & Development?

China Reinsurance (Group) HKSE:01508 -0.80% 78 Research & Development is HK$0 Mil as of Jun. 2026. GuruFocus rates HKSE:01508 with a GF Score™ of 78/100 and a GF Value™ of HK$1.14 (Fairly Valued). The stock has 2 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. China Reinsurance (Group)'s Research & Development for the six months ended in Jun. 2026 was HK$0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Jun. 2026 was HK$0 Mil.

China Reinsurance (Group)  (HKSE:01508) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

China Reinsurance (Group) Research & Development Related Terms

China Reinsurance (Group) Research & Development Historical Data

* Premium members only.

The historical data trend for China Reinsurance (Group)'s Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

China Reinsurance (Group) Research & Development Chart

China Reinsurance (Group) Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

China Reinsurance (Group) Semi-Annual Data
Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
HKSE:01508
78GF Score
China Reinsurance (Group) Corp HKSE:01508
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

China Reinsurance (Group) Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Jun. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of HK$0 Mil mean?
China Reinsurance (Group) (HKSE:01508) has a Research & Development of HK$0 Mil as of Jun. 2026. Research and development expense is the total cost for research and development activities. View historical data on China Reinsurance (Group) and its competitors.
Is China Reinsurance (Group)'s Research & Development too high?
China Reinsurance (Group)'s current Research & Development is HK$0 Mil. Overall, China Reinsurance (Group) has a GF Score™ of 78/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does China Reinsurance (Group)'s Research & Development compare to RGA and EG?
China Reinsurance (Group)'s Research & Development of HK$0 Mil can be compared against companies in the Insurance industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for an Insurance company?
A good Research & Development depends on the Insurance industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on China Reinsurance (Group) and its competitors. China Reinsurance (Group)'s current Research & Development is HK$0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is China Reinsurance (Group) stock overvalued right now?
Based on GuruFocus' analysis, China Reinsurance (Group) (HKSE:01508) is currently considered Fairly Valued. The stock's GF Value™ is HK$1.14, compared to a current price of HK$1.24 — trading 8.8% above its estimated fair value. The current Research & Development is HK$0 Mil. China Reinsurance (Group)'s overall GF Score™ is 78/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For China Reinsurance (Group) (HKSE:01508), the current Research & Development is HK$0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is China Reinsurance (Group) (HKSE:01508) Overvalued in 2026?

Based on GuruFocus' analysis, China Reinsurance (Group) stock appears to be overvalued. The current stock price of HK$1.24 is trading 8.8% above its estimated GF Value™ of HK$1.14. GuruFocus considers China Reinsurance (Group) to be Fairly Valued.

Key valuation signals for HKSE:01508:

  • Research & Development: HK$0 Mil
  • GF Value™: HK$1.14 vs. price of HK$1.24 (8.8% above fair value)
  • GF Score™: 78/100 with 2 warning signs

No single metric tells the full story. See the HKSE:01508 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

China Reinsurance (Group) Business Description

Other Exchanges C53:Germany
Address No. 11 Jinrong Avenue, Xicheng District, Beijing, CHN, 100033
China Reinsurance (Group) Corp is mainly engaged in property and casualty reinsurance, life and health reinsurance, primary property and casualty insurance, asset management and other businesses. Its operating and reportable segments are Property and casualty reinsurance segment offers a wide variety of reinsurance products; Life and health reinsurance segment offers a wide range of reinsurance products; Primary property and casualty insurance segment offers a wide variety of insurance products and other businesses including motor, property and liability insurance; Asset management segment offers asset management services; and Other segments of which majority of revenue comes from Primary property and casualty insurance.
78GF Score

Get the complete analysis for HKSE:01508

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$1.24
Price
HK$1.14
GF Value